Preventive Healthcare Targeted (China)
This article was originally published in PharmAsia News
Preventive medicine may be the first step toward Chinese healthcare reform, according to a representative for the Development Research Center of the State Council, Ge Yanfeng. He said the government needs to improve access to preventive procedures, many of which are not currently covered by health insurance. Many serious illnesses, including heart problems, cancer, and diabetes, could be targeted using preventive measures. Under the current system, the government finances only 5 percent of public and state-owned hospitals. The lack of funding has driven many institutions to prescribe unnecessary drugs and procedures to patients. Ge hopes expanding state funding of preventive care would curtail this practice. (Click here for more
You may also be interested in...
Private Company Edition: Venture capital financings didn’t take a break during Thanksgiving week. In addition to the $800m Resilience raised to fund manufacturing services, SomaLogic closed a $121m series A round to fund its proteomic tools for drug discovery and diagnostics development.
The $250m deal adds A&E Medical’s sternal sutures, cable systems, and rigid fixation systems to Zimmer Biomet’s Dental, Spine & Craniomaxillofacial and Thoracic business.
The Phase III clinical trial showed a noticeable placebo effect compared with OV101.